These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16705583)

  • 1. Erythema migrans in solid-organ transplant recipients.
    Maraspin V; Cimperman J; Lotric-Furlan S; Logar M; Ruzić-Sabljić E; Strle F
    Clin Infect Dis; 2006 Jun; 42(12):1751-4. PubMed ID: 16705583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
    Fürst B; Glatz M; Kerl H; Müllegger RR
    Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythema migrans in the immunocompromised host.
    Maraspin V; Lotric-Furlan S; Cimperman J; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):923-32. PubMed ID: 10666803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
    Maraspin V; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):616-9. PubMed ID: 12422612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.
    Feder HM; Abeles M; Bernstein M; Whitaker-Worth D; Grant-Kels JM
    Clin Dermatol; 2006; 24(6):509-20. PubMed ID: 17113969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of erythema migrans].
    Barsić B
    Lijec Vjesn; 1999; 121(4-5):148-53. PubMed ID: 10437360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans.
    Glatz M; Fingerle V; Wilske B; Ambros-Rudolph C; Kerl H; Müllegger RR
    Dermatology; 2008; 216(2):93-103. PubMed ID: 18216470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin.
    Arnez M; Pleterski-Rigler D; Luznik-Bufon T; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):498-504. PubMed ID: 12422590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple erythema migrans--manifestation of systemic cutaneous borreliosis.
    Egberts F; Möller M; Proksch E; Schwarz T
    J Dtsch Dermatol Ges; 2008 May; 6(5):350-3. PubMed ID: 18201222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of treatment for Lyme borreliosis: time for a critical reappraisal.
    Wormser GP; Nowakowski J; Nadelman RB
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):613-5. PubMed ID: 12422611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early-stage lyme borreliosis during pregnancy: treatment in 15 women with erythema migrans].
    Hercogová J; Tománková M; Frösslová D; Janovská D
    Cesk Gynekol; 1993 Oct; 58(5):229-32. PubMed ID: 8221915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance.
    Hunfeld KP; Ruzić-Sabljić E; Norris DE; Kraiczy P; Strle F
    Int J Med Microbiol; 2006 May; 296 Suppl 40():233-41. PubMed ID: 16530006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of Borrelia burgdorferi DNA shedding in urine after treatment.
    Aberer E; Bergmann AR; Derler AM; Schmidt B
    Acta Derm Venereol; 2007; 87(1):39-42. PubMed ID: 17225014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early diagnosis of Lyme borreliosis].
    Hofmann H
    MMW Fortschr Med; 2006 Jun; 148(25):32, 34, 36. PubMed ID: 16859158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythema (chronicum) migrans. The clinical variability of the earliest manifestation of Lyme borreliosis].
    Mrowietz U
    Dtsch Med Wochenschr; 1996 Aug; 121(31-32):988-93. PubMed ID: 8765403
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of Clinical Course and Treatment Outcome for Patients With Early Disseminated or Early Localized Lyme Borreliosis.
    Stupica D; Maraspin V; Bogovic P; Ogrinc K; Blagus R; Cerar T; Strle F
    JAMA Dermatol; 2018 Sep; 154(9):1050-1056. PubMed ID: 30073319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment of Lyme borreliosis: what is the evidence?
    Dinser R; Jendro MC; Schnarr S; Zeidler H
    Ann Rheum Dis; 2005 Apr; 64(4):519-23. PubMed ID: 15769910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyme borreliosis treatment.
    Vanousová D; Hercogová J
    Dermatol Ther; 2008; 21(2):101-9. PubMed ID: 18394084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Borrelial erythema of the face].
    de Heller-Milev M; Peter O; Panizzon RG; Laffitte E
    Ann Dermatol Venereol; 2008 Dec; 135(12):852-4. PubMed ID: 19084697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.